2026年11月11日,在美国心脏协会科学会议上公布的一项初步研究显示,含咖啡因和兴奋剂的补充剂与严重心血管急症报告之间存在显著关联 1。研究人员分析了2017年至2025年间提交给美国食品药品监督管理局(FDA)的28,345份可疑不良反应报告,其中854份涉及能量饮料或含咖啡因膳食补充剂,其余27,491份作为对照组 1。数据显示,此类产品涉及的心脏骤停报告频率约为无此类成分产品的11倍,心脏病发作报告频率为4.5倍,室性心律失常或心悸的报告频率则约为4倍 1。
约45%的相关心血管事件报告涉及18至34岁的年轻成年人 1。主要作者Sai Samayamanthula指出,定期饮用此类饮品可能导致消费者迅速超过每日推荐的咖啡因摄入量 1。Gregory M. Marcus博士强调,该研究并未证明因果关系,仅揭示了关联性,因此需要更多系统性的监测手段 1。目前,FDA将能量饮料归类为食品或膳食补充剂而非药物,这意味着它们不受同等严格的安全测试要求限制 1。与此同时,能量饮料行业的销售额在过去十年间翻了一番多,2024年已超过200亿美元 1。
A preliminary study presented at the American Heart Association's Scientific Sessions 2026 reveals a striking association between supplements containing caffeine and stimulants and severe cardiovascular emergencies 1. Researchers analyzed 28,345 suspected adverse event reports submitted to the Food and Drug Administration (FDA) between 2017 and 2025 1. Among these submissions, 854 involved energy drinks or caffeinated dietary supplements, while the remaining 27,491 served as a control group for products lacking such ingredients 1. The data indicates that reports involving these stimulant-containing products featured cardiac arrest at approximately 11 times the frequency seen in the control group 1. Additionally, heart attack reports were about 4.5 times more common, and instances of ventricular arrhythmia or palpitations occurred roughly four times more frequently among users of these supplements 1.
The findings highlight a concerning demographic trend, with nearly 45% of the reported cardiovascular events linked to these products involving young adults aged 18 to 34 1. This age group represents a significant portion of the energy drink market, which has seen its sales more than double over the past decade, exceeding $20 billion in 2024 1. Despite the growing popularity of these beverages, they are regulated by the FDA as foods or dietary supplements rather than drugs, meaning they do not undergo the same rigorous safety testing requirements mandated for pharmaceuticals 1.
While the statistical link is strong, experts caution against interpreting the results as proof of causation. Gregory M. Marcus emphasized that the research does not establish a direct causal relationship but underscores the need for enhanced systematic monitoring 1. Sai Samayamanthula, the study’s lead author, noted that regular consumption of these products can quickly cause individuals to exceed recommended daily caffeine intake levels 1. The presentation took place on November 11, 2026, by researchers from the University of Virginia School of Medicine in collaboration with the American Heart Association 1.
评论
还没有评论,欢迎留下第一条。